Johnson & Johnson Reveals Its Drug-Development Plans
J&J's overhaul will see it tackling conditions like lung cancer, eye disease, RSV and more. A top company scientist said J&J expects multi-billion-dollar income from new drugs by 2025. Separately, CVS will close 900 stores across the U.S.